V17A (p.Val17Ala) variant of MSH2 (DNA mismatch repair protein Msh2)

V17A (p.Val17Ala) in MSH2 (DNA mismatch repair protein Msh2) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance in the context of in gastric cancer. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes structural context.

V17A (p.Val17Ala) variant details